Is it safe? · Pregnancy Smart
How many weeks pregnant for the NIPT blood test?
What does the evidence say about NIPT test timing during pregnancy?
- Clinical reviews describe 10 weeks as the usual lower boundary for NIPT because placental cell-free DNA fraction is lower earlier in pregnancy. 1
- Fetal fraction tends to rise with gestational age, while maternal weight and other factors can affect whether a sample produces a reportable result. 2
- A systematic review describes fetal fraction as commonly around 10% to 15% between 10 and 20 weeks, with variation among patients and methods. 3
- A prenatal screening guideline recommends cell-free DNA screening after 10 weeks and explains that screening is distinct from follow-up testing. 4
- A low fetal fraction or no-call result should be discussed with the prenatal team because redraw timing, another screening method, or follow-up testing depends on the reason and gestational timing. 2
Is NIPT test timing safe in each trimester?
- First trimester. NIPT is generally discussed from about 10 weeks. Your clinician can review dating, fetal fraction factors, and whether another screening or follow-up option fits.
- Second trimester. If testing is done in the second trimester, your clinician can explain how NIPT fits with other screening and what a high-risk or no-call result means.
- Third trimester. A late test may still be possible, but timing depends on your care plan and the decision window for follow-up. Ask what result and follow-up options remain available.
Frequently asked questions
Why can’t NIPT be done before 10 weeks?
Before 10 weeks, placental cell-free DNA may be too small a share of the blood sample for a reportable result. Some methods may study earlier testing, but your clinician should explain the method and its no-call risk.
What happens if NIPT comes back with a low fetal fraction?
Your prenatal team may discuss a redraw, another screening option, or follow-up testing. The next step depends on gestational age, the reason for the low fraction, and your preferences.
Is NIPT the same as the first-trimester screen?
No. NIPT analyzes placental cell-free DNA in maternal blood, while first-trimester screening combines different measurements. Both are screening tests, and neither alone confirms a fetal condition.
How soon do NIPT results come back?
The return time depends on the laboratory and your clinician’s process. Ask when to expect the report and how a high-risk, low-fraction, or no-call result will be explained.
Can newer NIPT methods test earlier than 10 weeks?
Some research explores earlier or enhanced fetal-fraction methods, but 10 weeks remains the commonly cited clinical starting point in the reviewed guidance. Ask which method your laboratory uses.
Does NIPT tell you the baby’s sex?
Some NIPT panels report sex chromosome information, but panel content varies. Ask your clinician what your selected test reports and how those findings are interpreted.
Does a high-risk NIPT result confirm a fetal condition?
No. NIPT estimates the chance of certain chromosome conditions. A high-risk result needs counseling and an offer of confirmatory testing, such as chorionic villus sampling or amniocentesis when appropriate. Discuss the result and options before making pregnancy decisions.
Can NIPT be done at 12 weeks?
Yes, 12 weeks is within the usual window for NIPT. Your clinician will still consider dating, fetal fraction factors, and which follow-up options would be available for your result.
Related in the library
Comparisons
Genetic screening test timeline by trimester
Is it safe?
When are you screened for anemia during pregnancy?
Is it safe?
Is it too late to start folic acid once you're pregnant?
Comparisons
Muscle Relaxer Alternatives During Pregnancy
Is it safe?
When is the glucose test done for gestational diabetes?
Is it safe?
When is cervical length screened for preterm birth risk?
Symptoms
Faint positive pregnancy test
References
Fetal fraction and noninvasive prenatal testing: What clinicians need to know
NIH PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC10040212/
Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review
NIH PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC8829468/
Maternal and Fetal Factors Affecting Cell-Free Fetal DNA (cffDNA) Fraction: A Systematic Review
NIH PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC10757682/
NIH PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC7834900/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
